JMP Securities Healthcare News

This is selected healthcare news for JMP Securities, which is filed under Capital Firms. There are 1.6K news items for this page. JMP Securities is occasionally combined with Spectrum Pharmaceuticals, Relay Therapeutics and Veeva Systems in news items. A press release filter page is also available for JMP Securities.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
12/2/2022 Spectrum Pharmaceuticals (NASDAQ:SPPI) Receives New Coverage from Analysts at StockNews.com
... on Tuesday. The firm issued a sell rating on the biotechnology company's stock. A number of other brokerages have also weighed in on SPPI. JMP Securities restated a buy rating and issued a $4.00 price objective on shares of Spectrum Pharmaceuticals in a report on Friday, September 23rd. B ...
Daily Political
12/2/2022 StockNews.com Begins Coverage on Spectrum Pharmaceuticals (NASDAQ:SPPI)
... morning. The brokerage issued a sell rating on the biotechnology company's stock. Other equities research analysts also recently issued research reports about the company. JMP Securities restated a buy rating and issued a $4.00 target price on shares of Spectrum Pharmaceuticals in a research report on Friday, September 23rd ...
rivertonroll.com
12/2/2022 Immutep to Participate in The JMP Securities Hematology and
... a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announced that Marc Voigt, CEO, will participate in The JMP Securities Hematology and Oncology Summit, a virtual investor event to be held from December 6-7, 2022. Presentation Details : Date: Wednesday, 7 December 2022 Time ...
Globe Newswire
12/1/2022 Why Shares of Compugen Rose 16.5% on Wednesday
... operations. The biotech company also announced that it was sending CEO Anat Cohen-Dayag and other members of its management team to speak at a JMP Securities Hematology and Oncology Summit on Dec. 6. It's‚A ...
upstract.com
12/1/2022 Adicet Bio to Present at the Virtual JMP Securities Hematology and Oncology Summit
Adicet Bio to Present at the Virtual JMP Securities Hematology and Oncology Summit REDWOOD CITY, Calif. & BOSTON‚Ai(BUSINESS WIRE)‚AiAdicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that Chen Schor, President and Chief Executive ...
pharmaceuticaldaily.com
12/1/2022 Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022
Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022 ‚Ai Presentation to be webcast on www.exelixis.com ‚Ai ALAMEDA, Calif.‚Ai(BUSINESS WIRE)‚AiExelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in a fireside chat at the virtual JMP Securities Hematology ...
pharmaceuticaldaily.com
12/1/2022 Aura Biosciences Announces Pricing of Public Offering of Common Stock
... at the public offering price, less the underwriting discount. SVB Securities, Cowen and Evercore ISI are acting as joint bookrunning managers for the offering and JMP Securities, a Citizens Company, and BTIG are acting as co-managers for the offering. A shelf registration statement relating to the shares of common ...
Yahoo News
12/1/2022 Stock Market | FinancialContent Business Page
... at the public offering price, less the underwriting discount. SVB Securities, Cowen and Evercore ISI are acting as joint bookrunning managers for the offering and JMP Securities, a Citizens Company, and BTIG are acting as co-managers for the offering. A shelf registration statement relating to the shares of common ...
financialcontent.com
12/1/2022 Aura Biosciences Announces Pricing of Public Offering of...
... at the public offering price, less the underwriting discount. SVB Securities, Cowen and Evercore ISI are acting as joint bookrunning managers for the offering and JMP Securities, a Citizens Company, and BTIG are acting as co-managers for the offering. A shelf registration statement relating to the shares of common ...
marketwirenews.com
12/1/2022 Aura Biosciences Announces Pricing of Public Offering of Common Stock - Aura Biosciences (NASDAQ:AURA) - Benzinga
... at the public offering price, less the underwriting discount. SVB Securities, Cowen and Evercore ISI are acting as joint bookrunning managers for the offering and JMP Securities, a Citizens Company, and BTIG are acting as co-managers for the offering. A shelf registration statement relating to the shares of common ...
Benzinga
12/1/2022 Aura Biosciences Announces Pricing of Public Offering of Common Stock
... at the public offering price, less the underwriting discount. SVB Securities, Cowen and Evercore ISI are acting as joint bookrunning managers for the offering and JMP Securities, a Citizens Company, and BTIG are acting as co-managers for the offering. A shelf registration statement relating to the shares of common ...
Business Wire
12/1/2022 Spectrum Pharmaceuticals (NASDAQ:SPPI) Coverage Initiated at StockNews.com
... on Spectrum Pharmaceuticals from $6.00 to $4.00 and set a ‚Aubuy‚Au rating on the stock in a research report on Friday, November 25th. Finally, JMP Securities reiterated a ‚Aubuy‚Au rating and set a $4.00 price target on shares of Spectrum Pharmaceuticals in a research report on Friday, September ...
com-unik.info
12/1/2022 Protagonist Therapeutics to Participate in the JMP Securities Hematology and Oncology Summit
... V. Patel , Ph.D., President and Chief Executive Officer, will participate in a fireside chat presentation and host one-on-one meetings with investors at the JMP Securities Hematology and Oncology Summit, a virtual investor event taking place December 6-7, 2022 . Presentation Details: Date: December 6, 2022 Time: 11:40 a.m. ET ...
PR Newswire
12/1/2022 2022-12-01 | NDAQ:PTGX | Press Release | Protagonist Therapeutics Inc.
... V. Patel , Ph.D., President and Chief Executive Officer, will participate in a fireside chat presentation and host one-on-one meetings with investors at the JMP Securities Hematology and Oncology Summit, a virtual investor event taking place December 6-7, 2022 . Presentation Details: Date: December 6, 2022 Time: 11:40 a.m. ET ...
stockhouse.com
12/1/2022 Deciphera Pharmaceuticals, Inc. to Present at the JMP Securities Hematology and Oncology Summit
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a virtual fireside chat at the JMP Securities Hematology and Oncology Summit on Tuesday, December 6, 2022 at 10:40 AM ET. A live webcast of the fireside chat will be available on ...
inyoregister.com
12/1/2022 Deciphera Pharmaceuticals, Inc. to Present at the JMP Securities Hematology and Oncology Summit
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a virtual fireside chat at the JMP Securities Hematology and Oncology Summit on Tuesday, December 6, 2022 at 10:40 AM ET. A live webcast of the fireside chat ...
acrofan.com
12/1/2022 Terns Pharmaceuticals to Present at the 2022 JMP Securities Hematology and Oncology Summit
... address serious diseases, including oncology, obesity and non-alcoholic steatohepatitis (NASH), today announced that management will participate in a fireside chat at the 2022 Virtual JMP Securities Hematology and Oncology Summit on Tuesday, December 6 at 2:40 p.m. ET. ‚AuWe are delighted to participate in this hematology focused summit as ...
forextv.com
12/1/2022 Terns Pharmaceuticals to Present at the 2022 JMP Securities
... address serious diseases, including oncology, obesity and non-alcoholic steatohepatitis (NASH), today announced that management will participate in a fireside chat at the 2022 Virtual JMP Securities Hematology and Oncology Summit on Tuesday, December 6 at 2:40 p.m. ET. ‚AuWe are delighted to participate in this hematology focused summit as ...
Globe Newswire
11/30/2022 Taysha Gene Therapies to Participate in JMP Securities Hematology and Oncology Summit
... treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced that it will participate in the JMP Securities Hematology and Oncology Summit, which is taking place virtually from Tuesday, December 6, 2022, through Wednesday, December 7, 2022. Taysha's President, Founder ...
biotechwinners.com
11/30/2022 Taysha Gene Therapies (TSHA) Taysha Gene Therapies to Participate in JMP Securities Hematology and Oncology Summit
Taysha Gene Therapies to Participate in JMP Securities Hematology and Oncology Summit DALLAS, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central ...
researchpool.com
11/30/2022 Spectrum Pharmaceuticals (NASDAQ:SPPI) Coverage Initiated by Analysts at StockNews.com - Ticker Report
... objective on Spectrum Pharmaceuticals from $6.00 to $4.00 and set a buy rating for the company in a research report on Friday, November 25th. Finally, JMP Securities restated a buy rating and set a $4.00 target price on shares of Spectrum Pharmaceuticals in a report on Friday, September 23rd. One ...
Ticker Report
11/30/2022 Spectrum Pharmaceuticals (NASDAQ:SPPI) Now Covered by StockNews.com - Watch List News
... on shares of Spectrum Pharmaceuticals from $6.00 to $4.00 and set a buy rating on the stock in a research note on Friday, November 25th. JMP Securities restated a buy rating and set a $4.00 price objective on shares of Spectrum Pharmaceuticals in a research report on Friday, September 23rd ...
watchlistnews.com
11/30/2022 Iovance Biotherapeutics to Present at Upcoming Conferences
... the following conferences: Piper Sandler 34 th Annual Healthcare Conference Fireside Chat: November 30, 2022 at 10:30 a.m. ET / 7:30 a.m. PT New York, NY JMP Securities Hematology and Oncology Summit Fireside Chat: December 7, 2022 at 11:00 a.m. ET / 8:00 a.m. PT Virtual 41 st Annual J.P. Morgan Healthcare ...
Globe Newswire
11/30/2022 CTI BioPharma to Present at the JMP Securities Hematology and Oncology Summit
SEATTLE , Nov. 30, CTI BioPharma Corp. (NASDAQ: CTIC ) today announced that management will participate in a fireside chat at the JMP Securities Hematology and Oncology Summit at 3:00 p.m. ET . The conference will be held in a virtual meeting format. Presentation details: Event: JMP Securities Hematology and Oncology Summit Date ...
PR Newswire
11/30/2022 HOOKIPA to Participate in The JMP Securities Hematology and
... class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the company will participate virtually in investor meetings and panel discussions at The JMP Securities Hematology and Oncology Summit, December 6 - 7, 2022. About HOOKIPA HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on ...
Globe Newswire